Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
45 46 Search
2025
Role of Bcl-2 family anti-apoptosis inhibition in overcoming therapeutic resistance in prostate cancer: A systematic review
Critical Reviews in Oncology/Hematology
2025
A Critical Review on BH3 Mimetic Drugs and the Treatment of Cancer‐Associated Thrombosis (CAT): A Proposed Design for a Drug Delivery System Capable of Simultaneously Targeting Tumor Cells and Activated Platelets
Cancer Medicine
2023
IN SILICO STUDY OF THE SYNERGISTIC INTERACTION OF 5-FLUOROURACIL AND CURCUMIN ANALOGUES AS INHIBITORS OF B-CELL LYMPHOMA 2 PROTEIN
International Journal of Applied Pharmaceutics
2023
Protein Levels of Anti-Apoptotic Mcl-1 and the Deubiquitinase USP9x Are Cooperatively Upregulated during Prostate Cancer Progression and Limit Response of Prostate Cancer Cells to Radiotherapy
Cancers
2022
Mechanisms of cancer cell death induction by paclitaxel: an updated review
Apoptosis
2022
Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections
Frontiers in Immunology
2022
Novel BH4-BCL-2 Domain Antagonists Induce BCL-2-Mediated Apoptosis in Triple-Negative Breast Cancer
Cancers
2021
Dual Akt and Bcl-2 inhibition induces cell-type specific modulation of apoptotic and autophagic signaling in castration resistant prostate cancer cell lines
Molecular Biology Reports
2021
Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
2021
Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer
Cancers
2021
Novel Therapies in Myeloproliferative Neoplasms: Beyond JAK Inhibitor Monotherapy
Journal of Immunotherapy and Precision Oncology
2020
Mechanisms of Taxane Resistance
Cancers
2020
Peptidomimetics: A Synthetic Tool for Inhibiting Protein–Protein Interactions in Cancer
International Journal of Peptide Research and Therapeutics
2020
AT101 [(-)-Gossypol] Selectively Inhibits MCL1 and Sensitizes Carcinoma to BH3 Mimetics by Inducing and Stabilizing NOXA
Cancers
2020
Gut Microbiome Critically Impacts PCB-induced Changes in Metabolic Fingerprints and the Hepatic Transcriptome in Mice
Toxicological Sciences
2019
ABT-737 and erufosine combination against castration-resistant prostate cancer
Anti-Cancer Drugs
2019
Exploring Proteomic Drug Targets, Therapeutic Strategies and Protein - Protein Interactions in Cancer: Mechanistic View
Current Cancer Drug Targets
2019
Regulating the BCL2 Family to Improve Sensitivity to Microtubule Targeting Agents
Cells
2019
Activation of Piezo1 sensitizes cells to TRAIL-mediated apoptosis through mitochondrial outer membrane permeability
Cell Death & Disease
2018
Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin
Oncotarget
2018
Inhibiting Multiple Deubiquitinases to Reduce Androgen Receptor Expression in Prostate Cancer Cells
Scientific Reports
2018
Synergistic cytotoxicity of a prostate cancer-specific immunotoxin in combination with the BH3 mimetic ABT-737
Cancer Immunology, Immunotherapy
2017
Implications of Bcl-2 and its interplay with other molecules and signaling pathways in prostate cancer progression
Expert Opinion on Therapeutic Targets
2017
Neural Stem Cell Transplantation Is Associated with Inhibition of Apoptosis, Bcl-xL Upregulation, and Recovery of Neurological Function in a Rat Model of Traumatic Brain Injury
Cell Transplantation
2017
BH3 Mimetics for the Treatment of Prostate Cancer
Frontiers in Pharmacology
2017
CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer
Oncotarget
2016
Inhibition of Bcl-2 family members sensitises soft tissue leiomyosarcomas to chemotherapy
British Journal of Cancer
2016
Bim directly antagonizes Bcl-xl in doxorubicin-induced prostate cancer cell apoptosis independently of p53
Cell Cycle
2016
Enhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells
Experimental and Therapeutic Medicine
2016
Improving Taxane-Based Chemotherapy in Castration-Resistant Prostate Cancer
Trends in Pharmacological Sciences
2016
Physiological and Pharmacological Control of BAK, BAX, and Beyond
Trends in Cell Biology
2015
Antitumor activity of paclitaxel is significantly enhanced by a novel proapoptotic agent in non–small cell lung cancer
Journal of Surgical Research
2015
Atelocollagen-Mediated Intravenous siRNA Delivery Specific to Tumor Tissues Orthotopically Xenografted in Prostates of Nude Mice and Its Anticancer Effects
Nucleic Acid Therapeutics
2015
Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside
Current Opinion in Pharmacology
2015
Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL
Oncotarget
2015
Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy
Oncotarget
2015
Combining Paclitaxel with ABT-263 Has a Synergistic Effect on Paclitaxel Resistant Prostate Cancer Cells
PLOS ONE
2015
Broad targeting of resistance to apoptosis in cancer
Seminars in Cancer Biology
2015
Mcl-1 protects prostate cancer cells from cell death mediated by chemotherapy-induced DNA damage
Oncoscience
2014
Protein kinase C in the wood frog,Rana sylvatica: reassessing the tissue-specific regulation of PKC isozymes during freezing
PeerJ
2014
Synergistic Antitumor Activities of Docetaxel and Octreotide Associated with Apoptotic-Upregulation in Castration-Resistant Prostate Cancer
PLoS ONE
2014
Gonadotropin-Releasing Hormone Agonists Sensitize, and Resensitize, Prostate Cancer Cells to Docetaxel in a p53-Dependent Manner
PLoS ONE
2014
Rapid screening of protein–protein interaction inhibitors using the protease exclusion assay
Biosensors and Bioelectronics
2014
Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition
Oncotarget
2014
Emodin enhances ATRA-induced differentiation and induces apoptosis in acute myeloid leukemia cells
International Journal of Oncology
Additional cited-by details will be shown when available from Crossref